
Canaccord Genuity Reaffirms Their Hold Rating on Cochlear (CHEOF)
In addition to Canaccord Genuity, Cochlear also received a Hold from Citi’s Laura Sutcliffe in a report issued on September 18. However, on September 26, Morgan Stanley maintained a Sell rating on Cochlear (Other OTC: CHEOF).
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

